Stay updated on CHS-388 Study in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the CHS-388 Study in Advanced Solid Tumors Clinical Trial page.

Latest updates to the CHS-388 Study in Advanced Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check21 days agoChange DetectedRevision: v3.3.2 replaces v3.2.0; there are no visible changes to core study content such as eligibility, endpoints, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check28 days agoChange DetectedThe study now lists 23 locations, including University of Washington (Seattle) and Moffitt Cancer Center (Tampa), with the last update posted in November 2025.SummaryDifference1.0%

- Check49 days agoChange DetectedThe changes appear limited to formatting/layout adjustments on the Study Details page, with no modifications to core trial information such as status, enrollment, locations, inclusion/exclusion criteria, or measured outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check71 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference2%

- Check78 days agoChange DetectedCore content terminology updated from 'Clear cell renal carcinoma' to 'Clear cell carcinoma of kidney'; version bumped from v3.0.2 to v3.1.0.SummaryDifference0.2%

- Check85 days agoChange DetectedThe page now references Coherus Oncology, Inc. instead of Coherus Biosciences, Inc.SummaryDifference0.2%

Stay in the know with updates to CHS-388 Study in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CHS-388 Study in Advanced Solid Tumors Clinical Trial page.